Natural Killer Cell Responses during Human γ-Herpesvirus Infections.
DNAM-1
Epstein–Barr virus (EBV)
Kaposi sarcoma associated herpesvirus (KSHV)
NKG2A
NKG2D
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
15 Jun 2021
15 Jun 2021
Historique:
received:
18
05
2021
revised:
09
06
2021
accepted:
10
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Herpesviruses are main sculptors of natural killer (NK) cell repertoires. While the β-herpesvirus human cytomegalovirus (CMV) drives the accumulation of adaptive NKG2C-positive NK cells, the human γ-herpesvirus Epstein-Barr virus (EBV) expands early differentiated NKG2A-positive NK cells. While adaptive NK cells support adaptive immunity by antibody-dependent cellular cytotoxicity, NKG2A-positive NK cells seem to preferentially target lytic EBV replicating B cells. The importance of this restriction of EBV replication during γ-herpesvirus pathogenesis will be discussed. Furthermore, the modification of EBV-driven NK cell expansion by coinfections, including by the other human γ-herpesvirus Kaposi sarcoma-associated herpesvirus (KSHV), will be summarized.
Identifiants
pubmed: 34203904
pii: vaccines9060655
doi: 10.3390/vaccines9060655
pmc: PMC8232711
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 310030B_182827
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 310030L_197952/1
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : CRSII5_180323
Organisme : Krebsliga Schweiz
ID : KFS-4962-02-2020
Références
Lancet. 1964 Mar 28;1(7335):702-3
pubmed: 14107961
Curr Opin Virol. 2016 Oct;20:71-77
pubmed: 27665065
Eur J Immunol. 2012 Feb;42(2):447-57
pubmed: 22105371
PLoS Pathog. 2015 Dec 01;11(12):e1005286
pubmed: 26624012
Immunol Rev. 2019 Jan;287(1):202-225
pubmed: 30565241
Haematologica. 2010 Dec;95(12):2080-7
pubmed: 20823128
J Clin Invest. 2017 Jan 3;127(1):306-320
pubmed: 27893462
Cell Rep. 2016 May 3;15(5):1088-1099
pubmed: 27117418
Science. 2013 Jul 12;341(6142):186-91
pubmed: 23846901
J Infect Dis. 2015 Jun 1;211(11):1842-51
pubmed: 25492914
Front Immunol. 2021 Mar 19;12:650028
pubmed: 33815410
Nat Commun. 2020 Jul 31;11(1):3849
pubmed: 32737300
Infect Agent Cancer. 2012 Apr 02;7:9
pubmed: 22469025
Immunity. 1998 Sep;9(3):395-404
pubmed: 9768759
Nat Microbiol. 2018 Feb;3(2):1-8
pubmed: 29292383
Eur J Immunol. 2002 Oct;32(10):2711-20
pubmed: 12355422
J Clin Invest. 2012 Oct;122(10):3769-80
pubmed: 23006327
Blood. 2021 Jun 10;137(23):3225-3236
pubmed: 33827115
J Infect Dis. 2021 Jul 2;224(1):175-183
pubmed: 33165540
Nat Biotechnol. 2014 Apr;32(4):364-72
pubmed: 24633240
Nat Med. 2012 Jun;18(6):961-6
pubmed: 22635007
Cell Rep. 2020 Oct 13;33(2):108249
pubmed: 33053346
Annu Rev Pathol. 2014;9:349-72
pubmed: 24111911
Adv Exp Med Biol. 2020;1231:23-32
pubmed: 32060843
Front Immunol. 2020 Jun 17;11:1231
pubmed: 32625211
Blood. 2011 Feb 3;117(5):1522-9
pubmed: 21119115
AIDS. 2000 Jun 16;14(9):1123-33
pubmed: 10894276
J Infect Dis. 2013 Jan 1;207(1):80-8
pubmed: 23100562
Blood. 2000 Nov 1;96(9):3118-25
pubmed: 11049992
Blood. 2020 Feb 27;135(9):644-655
pubmed: 31942615
Clin Exp Immunol. 1996 Mar;103(3):408-13
pubmed: 8608639
J Exp Med. 2001 Aug 6;194(3):235-46
pubmed: 11489943
Immunol Rev. 2019 Sep;291(1):174-189
pubmed: 31402499
Front Oncol. 2019 Aug 06;9:713
pubmed: 31448229
Nat Rev Microbiol. 2019 Nov;17(11):691-700
pubmed: 31477887
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11379-E11387
pubmed: 30429324
J Virol. 2011 Jan;85(1):165-77
pubmed: 20980506
J Immunol. 2014 May 15;192(10):4492-6
pubmed: 24740502
PLoS Pathog. 2013;9(11):e1003748
pubmed: 24244169
Immunity. 2000 Oct;13(4):497-506
pubmed: 11070168
PLoS Pathog. 2021 Jan 7;17(1):e1009091
pubmed: 33411730
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1656-61
pubmed: 18230726
Clin Cancer Res. 2021 Jul 1;27(13):3744-3756
pubmed: 33986022
Cell Rep. 2013 Oct 31;5(2):458-70
pubmed: 24120866
Cell Host Microbe. 2017 Jul 12;22(1):61-73.e7
pubmed: 28704654
N Engl J Med. 1989 Jun 29;320(26):1731-5
pubmed: 2543925
PLoS Pathog. 2013 Aug;9(8):e1003568
pubmed: 23966863
Biol Blood Marrow Transplant. 2010 Apr;16(4):469-81
pubmed: 20044012
Blood. 2004 Dec 1;104(12):3664-71
pubmed: 15304389
Cell Rep. 2021 May 4;35(5):109056
pubmed: 33951431
J Exp Med. 1998 May 4;187(9):1395-402
pubmed: 9565632
Semin Immunol. 2017 Jun;31:20-29
pubmed: 28888619
N Engl J Med. 2020 Feb 6;382(6):545-553
pubmed: 32023374
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16519-16528
pubmed: 31363046
Nat Microbiol. 2019 Mar;4(3):404-413
pubmed: 30664667
J Clin Immunol. 2015 Feb;35(2):112-8
pubmed: 25504528
J Clin Immunol. 2015 Jul;35(5):445-8
pubmed: 25947952
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9626-E9634
pubmed: 29078283
J Virol. 2007 Jan;81(2):474-82
pubmed: 17079298
Nat Rev Dis Primers. 2019 Jan 31;5(1):9
pubmed: 30705286
J Exp Med. 2000 Aug 7;192(3):337-46
pubmed: 10934222
Blood. 2004 Feb 15;103(4):1244-52
pubmed: 14576041
Oncotarget. 2016 Nov 8;7(45):72961-72977
pubmed: 27662664
Am J Hum Genet. 2006 Apr;78(4):721-7
pubmed: 16532402
J Infect Dis. 2020 Jun 16;222(1):111-120
pubmed: 32072172
Nat Rev Immunol. 2003 Feb;3(2):108-22
pubmed: 12563295
J Virol. 2015 Nov 04;90(2):947-58
pubmed: 26537677
J Virol. 2005 Jan;79(2):1296-307
pubmed: 15613356
Blood. 2011 Jan 6;117(1):53-62
pubmed: 20926771
PLoS Pathog. 2018 Jul 27;14(7):e1007179
pubmed: 30052684
Blood. 2013 Apr 4;121(14):2678-88
pubmed: 23325834
EMBO J. 1996 Jun 17;15(12):3117-26
pubmed: 8670812
PLoS Pathog. 2012 Jan;8(1):e1002486
pubmed: 22253598
N Engl J Med. 1995 May 4;332(18):1186-91
pubmed: 7700311
Blood. 2003 Apr 15;101(8):3052-7
pubmed: 12480696
J Clin Invest. 2016 Oct 3;126(10):3772-3782
pubmed: 27571408
FEMS Microbiol Rev. 2019 Mar 1;43(2):181-192
pubmed: 30649299
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):239-44
pubmed: 14688409
N Engl J Med. 2010 May 27;362(21):1993-2000
pubmed: 20505178
J Virol. 2012 Aug;86(16):8693-704
pubmed: 22674989
Biol Blood Marrow Transplant. 2016 Sep;22(9):1602-1607
pubmed: 27220262
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13765-70
pubmed: 9811875
Front Cell Infect Microbiol. 2020 Apr 21;10:162
pubmed: 32373555
J Pediatr. 2004 Apr;144(4):519-23
pubmed: 15069403
Blood Adv. 2018 May 22;2(10):1101-1114
pubmed: 29764843
Immunity. 2000 Sep;13(3):365-74
pubmed: 11021534
Oncotarget. 2017 May 17;8(31):50342-50358
pubmed: 28881567
Oncotarget. 2017 Feb 7;8(6):10238-10254
pubmed: 28052012
J Virol. 2012 Aug;86(15):7976-87
pubmed: 22623780
Cytotherapy. 2021 Feb 5;:
pubmed: 33558145
Blood. 2013 Apr 4;121(14):2669-77
pubmed: 23365458
Nature. 2011 Jul 27;475(7357):471-6
pubmed: 21796205
Nat Microbiol. 2018 Feb;3(2):172-180
pubmed: 29292384
Int J Cancer. 2019 Nov 1;145(9):2468-2477
pubmed: 31265124
J Infect Dis. 2016 Feb 1;213(3):432-8
pubmed: 26268853
Cell Rep. 2013 Dec 26;5(6):1489-98
pubmed: 24360958
Nat Genet. 1998 Oct;20(2):129-35
pubmed: 9771704
J Clin Virol. 2018 May;102:84-92
pubmed: 29525635
Nature. 1998 Oct 1;395(6701):462-9
pubmed: 9774102
J Exp Clin Cancer Res. 1997 Jun;16(2):171-6
pubmed: 9261743
PLoS Pathog. 2015 Sep 01;11(9):e1005135
pubmed: 26327622
J Immunol. 2004 Feb 1;172(3):1455-62
pubmed: 14734722
PLoS One. 2019 Dec 17;14(12):e0226436
pubmed: 31846480
J Clin Immunol. 2017 Jan;37(1):32-35
pubmed: 27770395
Blood. 2021 Feb 4;137(5):624-636
pubmed: 32902645
Br J Haematol. 2005 Apr;129(2):266-74
pubmed: 15813855
Nat Rev Immunol. 2020 Dec;20(12):739-755
pubmed: 32728220
Ann N Y Acad Sci. 2007 Jan;1096:37-43
pubmed: 17405914
Blood. 2010 Nov 18;116(20):4158-67
pubmed: 20671122
Blood. 2006 May 1;107(9):3624-31
pubmed: 16384928
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11963-8
pubmed: 9751773
Expert Opin Ther Targets. 2021 Apr;25(4):311-327
pubmed: 33719836
Blood. 2010 Nov 11;116(19):3853-64
pubmed: 20696944
Eur J Immunol. 2011 Jul;41(7):1958-68
pubmed: 21509779
Nat Med. 2003 Mar;9(3):307-14
pubmed: 12592401
J Exp Med. 1965 May 1;121:761-70
pubmed: 14278230
Blood. 2014 Oct 16;124(16):2533-43
pubmed: 25205117
Nat Med. 1996 Aug;2(8):906-11
pubmed: 8705861
J Clin Invest. 2012 Mar;122(3):821-32
pubmed: 22354167
APMIS. 2020 Feb;128(2):129-135
pubmed: 32133709
Scand J Immunol. 2007 Aug-Sep;66(2-3):335-44
pubmed: 17635811
Br J Haematol. 2005 Jul;130(1):92-5
pubmed: 16044583
Science. 1994 Dec 16;266(5192):1865-9
pubmed: 7997879
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):
pubmed: 28893942
Blood. 1996 Oct 15;88(8):3022-7
pubmed: 8874200
Cell Host Microbe. 2009 Apr 23;5(4):376-85
pubmed: 19380116
Oncoimmunology. 2017 Jun 20;6(9):e1341031
pubmed: 28932644